Growth Metrics

Rockwell Medical (RMTI) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Rockwell Medical (RMTI) over the last 13 years, with Q3 2025 value amounting to $124000.0.

  • Rockwell Medical's Gains from Investment Securities fell 1142.86% to $124000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $446000.0, marking a year-over-year increase of 721.15%. This contributed to the annual value of $2.0 million for FY2024, which is 8324.23% up from last year.
  • As of Q3 2025, Rockwell Medical's Gains from Investment Securities stood at $124000.0, which was down 1142.86% from $148000.0 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Gains from Investment Securities registered a high of $840000.0 during Q3 2023, and its lowest value of $10000.0 during Q2 2022.
  • Its 5-year average for Gains from Investment Securities is $179866.7, with a median of $138000.0 in 2024.
  • In the last 5 years, Rockwell Medical's Gains from Investment Securities soared by 120000.0% in 2023 and then tumbled by 8333.33% in 2024.
  • Over the past 5 years, Rockwell Medical's Gains from Investment Securities (Quarter) stood at $57000.0 in 2021, then soared by 431.58% to $303000.0 in 2022, then skyrocketed by 177.23% to $840000.0 in 2023, then crashed by 96.67% to $28000.0 in 2024, then skyrocketed by 342.86% to $124000.0 in 2025.
  • Its Gains from Investment Securities stands at $124000.0 for Q3 2025, versus $148000.0 for Q2 2025 and $146000.0 for Q1 2025.